1-9 of 9
Dougald Monroe, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Hemophilia Α Plasma Treated with Emicizumab, Factor IXa in Activated Prothrombin Complex Concentrates Is the Dominant Contributor to Enhanced Thrombin Generation

Dougald Monroe, PhD, Mirella Ezban, PhD, Maureane Hoffman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-139586
Published: 2020
Journal Articles

In Hemophilia Α Plasma Treated with Emicizumab, Factor IX Activation By Factor VIIa Drives Thrombin Generation

Dougald Monroe, PhD, Mirella Ezban, PhD, Maureane Hoffman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-139712
Published: 2020
Journal Articles

Characterization of a Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Activity for Emergency Hemostasis

Ammon Fager, MD PhD, Maureane Hoffman, MD PhD, Dougald Monroe, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3623.
https://doi.org/10.1182/blood-2019-124428
Published: 2019
Journal Articles

Histones Induce the Release of Extracellular Hemoglobin and Red Blood Cell-Derived Microvesicles with Procoagulant Activity

Denis Noubouossie, MD PhD, Juraj Sokol, MD PhD, Mark Gerard Piegore, BS, Anton Ilich, MD, Michael Wayne Henderson, MSc, Micah Mooberry, MD, Dougald Monroe, PhD, Nigel S. Key, MBChB, FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 2514.
https://doi.org/10.1182/blood-2018-99-118769
Published: 2018
Journal Articles

Biochemical Characteristics of Emicizumab Activity with Factors IXa, X, and VIIa

Dougald Monroe, PhD, Maureane Hoffman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1167.
https://doi.org/10.1182/blood-2018-99-116888
Published: 2018
Journal Articles

At Equal Doses FIXFc (Alprolix) Is Not Significanly Better in a Saphenous Vein Bleeding Model Than Recombinant FIX (BeneFix) Seven Days Post-Infusion

Brian Cooley, PhD, David M Mann, PhD, Dougald Monroe, PhD, Feng-Chang Lin, Paul E. Monahan, MD, Darrel W. Stafford, PhD
Journal: Blood
Blood (2015) 126 (23): 3490.
https://doi.org/10.1182/blood.V126.23.3490.3490
Published: 2015
Journal Articles

Novel Mouse Hemostasis Model for Real-Time Determination of Bleeding Time and Hemostatic Plug Composition

Wolfgang Bergmeier, PhD, Raymond Piatt, Brian G. Petrich, PhD, Dougald Monroe, PhD, Nigel Mackman, PhD, Todd M Getz, PhD
Journal: Blood
Blood (2014) 124 (21): 4177.
https://doi.org/10.1182/blood.V124.21.4177.4177
Published: 2014
Journal Articles

Reversal Of Dabigatran Anticoagulation By a 4-Factor Prothrombin Complex Concentrate: Correlation Between Effects On Parameters Of Thrombin Generation and Hemostatic Effect In Vivo

Maureane Hoffman, MD, PhD, Zoya Volovyk, PhD, Dougald Monroe, PhD
Journal: Blood
Blood (2013) 122 (21): 3643.
https://doi.org/10.1182/blood.V122.21.3643.3643
Published: 2013
Journal Articles

Downregulation Of Tissue Factor Expression In Human Pericytes In An Endothelial Cell Co-Culture Model

Stacey A. Snyder, PhD, Maureane Hoffman, MD, PhD, Dougald Monroe, PhD, Samantha L. Lasater
Journal: Blood
Blood (2013) 122 (21): 3524.
https://doi.org/10.1182/blood.V122.21.3524.3524
Published: 2013